Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 3:12:15.
doi: 10.1186/s40545-019-0176-z. eCollection 2019.

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector

Nur Sufiza Ahmad  1   2 , Ernieda Hatah  1 , Mohd Makmor-Bakry  1
Affiliations

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector

Nur Sufiza Ahmad et al. J Pharm Policy Pract. .

Abstract

Background: As part of the initiatives to increase price transparency for consumers, pharmaceutical industry in Malaysia have been encouraged to declare the wholesale and recommended retail prices (RRP) of medicines to the Pharmaceutical Service Department (PSD) yearly. However, the relationship between the voluntary price reporting practices and consumers' retail medicine price is unknown. Therefore, this study aims to evaluate the effect of the voluntary price reporting practice of pharmaceutical industry on retail medicine prices, factors that may affect consumer medicine prices in Malaysia's private healthcare sector, and the retail medicine pricing trend over 2011-2015.

Methods: A yearly correlation test for a 5-year period was performed to investigate the association between the wholesale and RRP medicine prices declared by the pharmaceutical industry from 2011 to 2015 on the one hand and the consumer wholesale and retail medicine price database on the other hand. The median price ratio (MPR) was calculated by comparing the consumer retail medicine price to its international reference price. The Krukal Wallis test was used to analyse the pricing trend throughout the 5-year period, and factors that might elevate the MPR above 2.5 were modelled using binary logistic regression.

Results: A total of 2527 medicine price data were analysed. There was a strong significant association between medicine prices declared to the PSD and the retail medicine prices in every year of the 5-year period. Moreover, there was no significant increase in retail medicine prices throughout the 5-year period. The medicine types, retail location, type of manufacturer, medicinal indications, declared wholesale and RRPs significantly influenced the consumer MPRs that where > 2.5.

Conclusion: The declared medicine price was found to have a significant association with the consumer retail medicine price. Thus, it may be a useful reference for consumers purchasing medicines in private healthcare settings. However, the government of Malaysia must develop strategies to increase medicine price transparency for price-control mechanisms in the private healthcare sector.

Keywords: Affordability; Drugs; Pharmaceutical pricing; Policy; Price information; Transparency.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thomas S, Beh L, Bin NR. Health care delivery in Malaysia: changes, challenges and champions. J Public Health Africa. 2011;2:93–97. doi: 10.4081/jphia.2011.e23. - DOI - PMC - PubMed
    1. Malaysian Investment Development Authority . Medical and healthcare services: Malaysia Investment in the Services Sector. 2017.
    1. Ministry of Health Malaysia. Malaysia national health Accounts health expenditure report 1997-2013. Putrajaya; 2015.
    1. Ministry of Health Malaysia. Malaysia National Health Accounts: Health expenditure report 1997-2015. Putrajaya; 2015. Available at: http://jknjohor.moh.gov.my/bmv/uploads/penerbitan/MNHA19972015.pdf. Accessed 2 May 2019.
    1. Hassali MA, Tan CS, Wong ZY, Saleem F, Alrasheedy AA. Pharmaceutical pricing in Malaysia. In: Babar Z-U-D, editor. Pharmaceutical prices in the 21st century. Cham: Springer International Publishing; 2015. pp. 171–188.